Gladys Berejiklian marks hospital redevelopment 'key milestone'

Premier visits Concord to tour redevelopment site and operating theatres

September 2019

Gladys Berejiklian marks hospital redevelopment 'key milestone'

Gladys Berejiklian marks hospital redevelopment 'key milestone'

Premier Gladys Berejiklian and Health Minister Brad Hazzard have officially opened two new operating theatres at Concord Hospital as construction ramps up on the $341 million redevelopment of the campus.

Ms Berejiklian, Mr Hazzard, and Minister for Veterans and Member for Drummoyne John Sidoti, marked the completion of enabling works for the rebuild, which will deliver world-class cancer, aged care and rehabilitation services.

In celebrating the “key milestone” they were joined by the Chair of the Board of Sydney Local Health District the Hon Ron Phillips AO, Chief Executive Dr Teresa Anderson AM, Concord Hospital Acting General Manager Dr Genevieve Wallace, Health Infrastructure Chief Executive Rebecca Wark and members of the Redevelopment project team.

The new 214-bed Clinical Services Building will boost the hospital campus capacity to more than 650 beds and will feature Australia’s first comprehensive care centre for veterans and their families.

Ms Berejiklian said the National Centre for Veterans’ Healthcare, which opened in a temporary location onsite last month and will be permanently housed in a purpose-built space in the new building, continues Concord’s “proud legacy”.

“The upgrade here at Concord is a special one,” Ms Berejiklian said.

“Concord Hospital has served both the local community and the men and women of the defence force for decades, and we owe this institution a great debt of gratitude,” Ms Berejiklian said.

During their visit, Ms Berejiklian, Mr Hazzard and Mr Sidoti met two patients who are part of a clinical trial for a rare type of blood cancer called acute promyelocytic leukaemia.

Under the care of Professor Judith Trotman, head of the Department of Haematology and Dr Jane Estell, head of the Clinical Research Unit, patients Kieran Hewer, 32, and George Anthony, 65, are being treated with targeted therapy of arsenic and retinoic acid (vitamin A).

Professor Trotman said this therapy has a 90 per cent cure rate and the trial is investigating if oral therapy can replace intravenous therapy.

“If successful, future patients will not need to spend as much time in hospital,” Professor Trotman said.

"I have to say today's visit in particular warmed my heart - to meet with patients who are going through a trial for the first time - but to also know that hopefully the success rate that they have will be the source of inspiration for so many across the state," Ms Berejiklian said.

The world-leading Haematology Department will relocate to the new Clinical Services Building as part of Concord’s Comprehensive Cancer Centre.

Mr Hazzard officially opened two refurbished operating theatres. The $1.3 million upgrade means the theatres are now fully digitally integrated and feature multiple screens, used for displaying radiological images and a large wall screen for teaching purposes.

A new communication system between theatres 7, 9 and 10 allows theatre staff to view each other’s theatres and talk to each other without having to leave the room. This saves surgeons having to un-scrub, scrub-in to another, and then repeat the process to re-enter their theatre.

The Clinical Services Building is due to be commissioned at the end of 2021. To find out more about the redevelopment see http://concordredevelopment.health.nsw.gov.au/


© 2020 Sydney Local Health District |  SLHD on YouTube   SLHD on Facebook
Disclaimer | Privacy Statement | Accessibility
Page Last Updated: 03 September, 2019